Nippon India CRISIL-IBX Financial Services 9-12 Months Debt Index Fund
Direct Plan · IDCW Option · Nippon India Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +0.18% | +3.19% | 250 of 283 |
| 1M | +0.27% | +2.85% | 225 of 283 |
| 3M | +1.23% | -2.37% | 40 of 283 |
| 6M | +3.12% | +1.56% | 45 of 278 |
| YTD | +4.16% | -0.86% | 55 of 283 |
| INCEPTION | +6.26% | — | — |
Ranked among: Other Scheme - Index Funds.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +1.78% | +2.42% | +1.18% | 100% | 41% |
| 6M | +3.39% | +3.74% | +2.88% | 100% | 41% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity0.00%
- Debt96.77%
- Cash3.23%
- Other0.00%
Market Cap Split
- Large Cap0.00%
- Mid Cap0.00%
- Small Cap0.00%
- Others100.00%
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Kotak Mahindra Prime Limited** | Money Market | 12.88% | — |
| L&T Finance Limited** | Money Market | 12.02% | — |
| Tata Capital Limited** | Money Market | 10.30% | — |
| BFL-9-9-27-CP | Money Market | 8.58% | — |
| 8.1% Tata Capital Housing Finance Limited** | Debt | 4.61% | -0.08% |
| PFCL-7.65%-22-11-27-PVT | Debt | 4.61% | — |
| 8% Tata Capital Housing Finance Limited** | Debt | 4.61% | — |
| 6.6% REC Limited | Debt | 4.57% | — |
| Bank of Baroda | Money Market | 4.47% | — |
| Indian Bank** | Money Market | 4.38% | — |
| Canara Bank** | Money Market | 4.37% | — |
| Small Industries Dev Bank of India | Money Market | 4.32% | — |
| Canara Bank** | Money Market | 3.58% | — |
| 7.7% REC Limited** | Debt | 2.77% | — |
| Triparty Repo | Reverse Repo / TREPS | 2.05% | — |
View all 25 holdings
| 8.19% Kotak Mahindra Investments Limited** | Debt | 1.85% | -0.02% |
| 8.1% Tata Capital Limited** | Debt | 1.85% | -0.02% |
| 7.72% Bajaj Finance Limited** | Debt | 1.84% | -9.38% |
| 7.8% LIC Housing Finance Limited** | Debt | 1.84% | — |
| HDFC Bank Limited** | Money Market | 1.79% | — |
| Net Current Assets | Net Current Assets | 1.17% | — |
| Small Industries Dev Bank of India** | Money Market | 0.89% | -4.51% |
| 7.65% HDB Financial Services Limited** | Debt | 0.46% | — |
| 8.25% Mahindra & Mahindra Financial Services Limited** | Debt | 0.18% | -0.76% |
| Cash Margin - CCIL | Net Current Assets | 0.01% | — |
Risk Metrics
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 3Y | 0.63 | 0.26 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
ICICI Prudential Nifty Pharma Index Fund
Direct Plan · IDCW
|
+22.53% | +22.50% | — | +21.44% |
|
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund
Direct Plan · Growth
|
+20.88% | +21.50% | +14.91% | +16.74% |
|
Tata Nifty Capital Markets Index Fund
Direct Plan · Growth Option
|
+19.89% | — | — | +21.71% |
|
Motilal Oswal Nifty Capital Market Index Fund
Regular Plan · Growth
|
+19.31% | — | — | +16.06% |
|
Motilal Oswal S&P 500 Index Fund
Direct Plan · GROWTH
|
+18.19% | +25.74% | +16.20% | +20.46% |
|
Tata Nifty MidSmall Healthcare Index Fund
Regular Plan · IDCW Payout Option
|
+17.24% | — | — | +17.73% |
|
Motilal Oswal Nifty MidSmall Healthcare Index Fund
Regular Plan · Growth
|
+17.19% | — | — | +11.55% |
|
ICICI Prudential NASDAQ 100 Index Fund
Regular Plan · Growth
|
+15.21% | +27.99% | +16.74% | +17.49% |
|
Bandhan BSE Healthcare Index Fund
Regular Plan · Growth
|
+13.22% | — | — | +7.26% |
|
Motilal Oswal Nifty India Defence Index Fund
Regular Plan · Growth
|
+13.06% | — | — | +4.19% |
More From Nippon Life India Asset Management Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
Nippon India Taiwan Equity Fund
Direct Plan · Growth Option
|
+61.78% | +49.40% | — | +24.96% |
|
Nippon India Silver ETF
Direct Plan
|
+26.05% | +36.23% | — | +25.08% |
|
Nippon India Silver ETF FOF
Direct Plan · IDCW Option
|
+24.99% | +35.38% | — | +24.09% |
|
Nippon India Nifty Pharma ETF
Direct Plan
|
+22.83% | +22.93% | +15.06% | +13.35% |
|
Nippon India Japan Equity Fund
Direct Plan · IDCW Option
|
+20.27% | +21.27% | +9.63% | +9.56% |
|
Nippon India ETF Gold BeES
Direct Plan
|
+16.58% | +30.82% | +23.10% | +15.30% |
|
Nippon India Gold Savings Fund
Direct Plan · Growth Option
|
+16.51% | +30.76% | +22.97% | +10.34% |
|
Nippon India US Equity Opportunities Fund
Direct Plan · IDCW Option
|
+11.90% | +18.73% | +10.93% | +14.93% |
|
Nippon India Pharma Fund
Direct Plan · Growth Option
|
+10.54% | +18.85% | +14.53% | +17.34% |
|
Nippon India Fixed Maturity Plan - XLV - Series 5
Direct Plan · Growth Option
|
+7.36% | +8.43% | — | +8.54% |
About This Scheme
Investment Objective
The investment objective of the scheme is to provide investment returns that are commensurate with the total returns of the securities as represented by the CRISIL-IBX Financial Services 9-12 Months Debt Index before expenses, subject to tracking errors. There is no assurance that the investment objective of the Scheme will be achieved
Stated Asset Allocation
Instruments representing the CRISIL-IBX Financial Services 9-12 Months Debt Index - 95%- 100%, Cash & cash equivalents and Money Market instruments and/ or Schemes which invest in the money market securities or Liquid Schemes#
Exit Load
Nil
Fund Managers
Mr. Vikash Agarwal
Primary
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch